T0	Participants 14 51	irresectable hepatocellular carcinoma
T1	Participants 140 164	SUMS and Lund university
T2	Participants 179 379	40 patients with the irresectable hepatocellular carcinoma (HCC) admitted to the department of HPB surgery in the First Affiliated Hospital of SUMS were randomized into two groups: (20 each) from Feb.
T3	Participants 380 400	1994 to April, 1995.